Use access key #2 to skip to page content.
  • S&P 500: 1,069.30
  • Change: 0.25%
$51.53 -0.09 (-0.17%)
11/6/2009 4:00 PM

Abbott Laboratories (ABT)

CAPS Rating:
*****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABT

Add Stock to Watchlist

What the Community Thinks

Abbott Laboratories At A Glance

Current Price: $51.53
Last Trade Time: 11/6/2009 4:00 PM
Open: $51.45
Previous Close: $51.62
Daily Range: $51.07 - $51.59
52-Week Range: $41.27 - $57.39
Volume: 3,994,612
Market Cap: $79.66B
P/E Ratio: 15.46
Compare Our Special Broker Offers!

Stock Trends

ABT VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for ABT

More Headlines...

Top Bull Pitch

Recs

1

Abbott Laboratories (ABT)

Avatar Shaftsbury (61.62) Submitted: 1/21/09 6:03 PM

This equity has been relatively flat of late compared to its peers, but has significantly outperformed the market over the past year. With an excellent earning report today and a very nice forecast for 2009, expect the stock to move higher, or at worst, to outperform in a bad market.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Abbott Laboratories (ABT)

Avatar boiseidfool (80.29) Submitted: 3/03/07 9:35 AM

Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the prices charged to hospitals and pharmacies for Ab...More

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 212 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ABT)

Avatar TrackMyself (25.23) Submitted: 10/21/09 9:08 PM : Outperform Start Price: $51.12 ABT Score: 1.78

Tracking some of my real portfolio

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar Blygh (< 20) Submitted: 10/19/09 4:34 PM : Outperform Start Price: $51.98 ABT Score: 1.70

Solid company - health care has under performed S&P 500 - improving earnings

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar grmind (71.63) Submitted: 10/16/09 8:19 PM : Outperform Start Price: $51.46 ABT Score: 1.91

Best of big pharma

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar deadrock (30.81) Submitted: 10/16/09 11:42 AM : Outperform Start Price: $51.59 ABT Score: 1.10

well run company with a relatively safe dividend

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar SWEAT7 (< 20) Submitted: 10/12/09 11:08 PM : Outperform Start Price: $49.77 ABT Score: 3.78

Abbott has been in a large growth slow movement pattern for a significant timeframe. after earning, expect ABT to break resistance for a 4 to 5 % tick up.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 212 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 24 of 24  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackHilliard 45.54 08/13/09 Outperform NS $43.82+17.60%+6.40%+11.19
TrackTobinSmith < 20 05/15/09 Outperform 1Y $42.60+20.97%+22.03%-1.06
TrackBarclaysCap 86.02 04/09/09 Outperform NS $41.82+23.21%+27.58%-4.37
TrackHeebner 23.58 11/25/08 Outperform 1Y $49.72+3.63%+25.80%-22.17 Toggle the visibility of 60-Second Pitch and replies
TrackLeerinkSwan 84.26 06/23/08 Outperform NS $51.02+1.00%-16.31%+17.31
TrackUBS 86.41 05/09/08 Outperform NS $48.88+5.42%-19.73%+25.15
TrackWachovia 35.10 03/20/08 Outperform NS $51.83-0.57%-14.57%+14.00
TrackStanfordRes 80.42 10/09/07 Outperform NS $51.55-0.04%-27.87%+27.83
TrackSnow 94.97 09/30/07 Outperform NS $50.24+2.57%-26.44%+29.01 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley < 20 09/30/07 Outperform NS $50.24+2.57%-26.44%+29.01 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 98.26 09/30/07 Outperform NS $50.24+2.57%-26.44%+29.01 Toggle the visibility of 60-Second Pitch and replies
TrackRichAster 91.10 09/30/07 Outperform NS $50.24+2.57%-26.44%+29.01 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 86.63 09/30/07 Outperform NS $50.24+2.57%-26.44%+29.01 Toggle the visibility of 60-Second Pitch and replies
TrackScottBleier 63.76 07/20/07 Outperform 3M $49.54+4.02%-26.53%+30.56
TrackLehmanBros 76.60 05/07/07 Outperform NS $54.89-6.12%-24.97%+18.85
TrackGaryBSmith 41.83 03/31/07 Outperform 3W $51.96-0.83%-20.24%+19.41
TrackMichaelSivy 90.71 03/20/07 Outperform 1Y $51.86-0.64%-19.66%+19.02
TrackMatrix 89.45 03/01/07 Outperform NS $49.77+3.54%-18.39%+21.93
TrackRBCCapMkts 81.74 01/25/07 Outperform NS $48.98+5.20%-20.87%+26.07
TrackAGEdwards 89.12 01/22/07 Outperform NS $49.26+4.61%-20.52%+25.13
TrackJimCramer < 20 12/06/06 Outperform 3W $44.45+15.92%-19.77%+35.68
TrackBofASec 93.50 09/05/06 Outperform NS $44.97+14.58%-13.16%+27.74
TrackRochdale 38.18 08/16/06 Outperform NS $45.37+13.58%-10.73%+24.31

Results 1 - 24 of 24  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD04 187ms